Streamex (NASDAQ: STEX) a technology company focused on commodity market tokenization, announced that Chief Financial Officer Christine Plummer will present at the ThinkEquity Conference on Oct. 15, 2026, at the Mandarin Oriental Hotel in New York City. The presentation is

Lantern Pharma (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, received regulatory and Institutional Review Board “IRB” approvals in Taiwan to open Part 2 of its Phase 2 HARMONIC(TM) trial of LP-300. The lead Taiwan site is open to accrual

American Fusion (OTC: AMFN), developer of the proprietary Texatron(TM) Fusion Engine(TM), entered into agreements to restructure existing stock-based compensation rights with an aggregate maximum contractual amount of $2.88 million into Series C Convertible Preferred Stock. The agreements cover 12 officers,

Most multiple sclerosis (“MS”) drugs work by quieting the immune system. A new partnership shines the spotlight on a different approach — protecting the nerve’s own insulation — and sets up that treatment for a rigorous clinical test. Quantum BioPharma

Host Digital (NYSE American: HOST), a vertically integrated digital infrastructure company, issued a shareholder letter from CEO Harmol Samra outlining its strategy to develop, own and operate RightScaled data centers for artificial intelligence “AI” and high-performance computing “HPC” workloads. The

VERAXA Biotech (NASDAQ: VRXA), a developer of next-generation antibody-based cancer therapies, provided an update on its strategy to implement U.S. Food and Drug Administration “FDA”-aligned New Approach Methodologies “NAMs” across its preclinical research and development programs. The company said the

Beeline Holdings (NASDAQ: BLNE), a digital mortgage platform, will host a stakeholder update call on its third-quarter 2026 results on Thursday, Nov. 12, at 5 p.m. ET. CEO Nick Liuzza and CFO Chris Moe will review the company’s performance and

Mobilicom (NASDAQ: MOB), a provider of cybersecure solutions for drones and robotics, announced its participation in the Association of the United States Army “AUSA” 2026 Annual Meeting & Exposition, taking place Oct. 12-14 in Washington, D.C., and the ThinkEquity Conference

Most multiple sclerosis (“MS”) drugs work by quieting the immune system. A new partnership shines the spotlight on a different approach — protecting the nerve’s own insulation — and sets up that treatment for a rigorous clinical test. Quantum BioPharma

Safe Pro Group (NASDAQ: SPAI), a developer of artificial intelligence “AI”-enabled defense, security and situational awareness solutions, expects preliminary, unaudited third-quarter 2026 revenue to increase more than 2,300% year over year to over $2.5 million from $101,422. For the first

Mobilicom (NASDAQ: MOB), a provider of cybersecure solutions for drones and robotics, announced its participation in the Association of the United States Army “AUSA” 2026 Annual Meeting & Exposition, taking place Oct. 12-14 in Washington, D.C., and the ThinkEquity Conference

Disseminated on behalf of LaFleur Minerals Inc. and may include paid advertising.

Blockchain adoption has increasingly moved beyond the question of whether businesses can use digital assets. The more important question is what infrastructure can support those applications as they become more complex and specialized.

As Western governments and manufacturers work to reduce their reliance on Chinese rare earth supply, Greenland has emerged as one of the most closely watched frontiers. The island hosts significant deposits of the magnet metals essential to electric vehicles, wind

Telomir Pharmaceuticals (NASDAQ: TELO) announced an approximately $5.6 million private investment in public equity (“PIPE”) financing through the issuance of 4,843,300 common shares at $1.16 per share, representing a 5% discount to the applicable 10-day volume-weighted average price. The financing

Earth Science Tech (OTCQB: ETST), a strategic holding company that brings together innovative businesses across the healthcare, pharmacy, technology and telemedicine, real estate, and consumer products spaces, operates Avenvi LLC, a real estate and asset management arm. Like its parent

NanoViricides, Inc. (NYSE American: NNVC) announced that it will present Oct. 7, 2026, at NIBA 153rd Investment Conference in Fort Lauderdale, Florida. The clinical-stage company is developing nanomedicines for antiviral therapy, led by NV-387, a broad-spectrum antiviral currently in separate

Quantum BioPharma (NASDAQ: QNTM) entered into a Study Start-Up Agreement (“SUA”) with the clinical research business of Thermo Fisher Scientific to implement its Phase 2 clinical trial of Lucid-21-302 (“Lucid-MS”) for multiple sclerosis (“MS”). The agreement initiates formal study start-up

The crypto sector poured roughly $8 million in the first six months of 2026 into lobbying efforts tied to U.S. legislation that would establish a regulatory framework for digital asset markets, according to federal disclosure records.

President Trump recently brought together some of the biggest names in technology, describing the White House gathering as an important meeting of executives driving what he called the U.S. “Golden Age.”